.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

FERAHEME Drug Profile

« Back to Dashboard
Feraheme is a drug marketed by Amag Pharms Inc and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has eleven patent family members in ten countries.

The generic ingredient in FERAHEME is ferumoxytol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ferumoxytol profile page.

Summary for Tradename: FERAHEME

Patents:6
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Drug Prices: :see details

Pharmacology for Tradename: FERAHEME

Ingredient-typeIron
Drug ClassParenteral Iron Replacement
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amag Pharms Inc
FERAHEME
ferumoxytol
SOLUTION;INTRAVENOUS022180-001Jun 30, 2009RXYes8,501,158► subscribe ► subscribe
Amag Pharms Inc
FERAHEME
ferumoxytol
SOLUTION;INTRAVENOUS022180-001Jun 30, 2009RXYes7,553,479► subscribeYY ► subscribe
Amag Pharms Inc
FERAHEME
ferumoxytol
SOLUTION;INTRAVENOUS022180-001Jun 30, 2009RXYes8,591,864► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: FERAHEME

Drugname Dosage Strength RLD Submissiondate
ferumoxytolInjection30 mg/mL, 17 mL single-use vialsFeraheme12/4/2015

International Patent Family for Tradename: FERAHEME

Country Document Number Estimated Expiration
Japan2002541218► subscribe
Japan2011046752► subscribe
Denmark1169062► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: FERAHEME

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1169062/01Switzerland► subscribePRODUCT NAME: FERUMOXYTOL; REGISTRATION NO/DATE: SWISSMEDIC 62033 17.08.2012
2012 00050Denmark► subscribe
90043-7Sweden► subscribePRODUCT NAME: FERUMOXYTOL; REG. NO/DATE: EU/1/12/774/001 20120615
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc